Action Novartis - 0K9E

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

76,79

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

883

0,00 Fourchette du Jour 0,00

76,79 Plage de 52 semaines 76,79

Cap du marché

151,667B

Clôture Veille

76,79

Ouverture

Dernière Transaction

112.2224

(O)

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

4 439

Actions en circulation

1 975 089 000

Rendement du Dividende

Ratio Cours sur Bénéfices

18,36

Bénéfice par action (BPA)

6,05

Chiffre d'affairess

51,72B

Bénéfice net

11,94B

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.novartis.com

Siège social

Basel, Che

Fondé

Novartis Ag est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0K9E. Le dernier cours de clôture d'Novartis était de US$76,79. Au cours de la dernière année, les actions de Novartis ont été négociées dans une fourchette de prix de US$ 76,79 à US$ 76,79.

Novartis compte actuellement 1 975 089 000 actions en circulation. La capitalisation boursière d'Novartis est de US$151,67 milliard. Novartis a un ratio cours/bénéfice (ratio PE) de 18.36.

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

N -- Full year net sales for continuing operations1 up 9% (cc2, +6% USD): -- Pharmaceuticals BU growing 12% (cc) driven by Cosentyx USD 3.6...

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

N -- Der Nettoumsatz der fortzuführenden Geschäftsbereiche1 steigt 2019 um 9% (kWk2, +6% USD): -- Die Geschäftseinheit...

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

N -- Hausse du chiffre d'affaires net des activités poursuivies1 de 9% sur l'exercice entier (tcc2, +6% USD): -- Pharmaceuticals:...

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

N Basel, January 6, 2020 -- Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced...

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

N -- Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication -- Fevipiprant was...

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

N Basel, December 5, 2019 -- Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa...

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

N -- Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia...

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

N -- Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 -- Adakveo reduced the annual rate...

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

N -- Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing...

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

N -- FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study...

Période	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	76.79	76.79	76.79	428	76.79	DE
4	76.79	76.79	76.79	508	76.79	DE
12	76.79	76.79	76.79	4439	76.79	DE
26	76.79	76.79	76.79	3450	76.79	DE
52	76.79	76.79	76.79	7301	76.79	DE
156	76.79	76.79	76.79	21486	76.79	DE
260	76.79	76.79	76.79	17756	76.79	DE

0K9E - Frequently Asked Questions (FAQ)

What is the current Novartis share price?

The current share price of Novartis is US$ 76,79

How many Novartis shares are in issue?

Novartis has 1 975 089 000 shares in issue

What is the market cap of Novartis?

The market capitalisation of Novartis is USD 151,67B

What is the 1 year trading range for Novartis share price?

Novartis has traded in the range of US$ 76,79 to US$ 76,79 during the past year

What is the PE ratio of Novartis?

The price to earnings ratio of Novartis is 18,36

What is the cash to sales ratio of Novartis?

The cash to sales ratio of Novartis is 4,24

What is the reporting currency for Novartis?

Novartis reports financial results in USD

What is the latest annual turnover for Novartis?

The latest annual turnover of Novartis is USD 51,72B

What is the latest annual profit for Novartis?

The latest annual profit of Novartis is USD 11,94B

What is the registered address of Novartis?

The registered address for Novartis is PO BOX, BASEL, 4002

What is the Novartis website address?

The website address for Novartis is www.novartis.com

Which industry sector does Novartis operate in?

Novartis operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
PREPensana Plc	27,90p (39,50%)	3,01M
INOVSchroders Capital Global Innovation Trust Plc	11,95p (37,04%)	12,46M
XTRXtract Resources Plc	1,125p (25,00%)	13,08M
HEITHarmony Energy Income Trust Plc	78,40p (20,25%)	14,89M
KAVKavango Resources Plc	0,75p (20,00%)	15,71M
ALGWAlpha Growth Plc	0,325p (-74,00%)	16,5M
HMIHarvest Minerals Limited	0,40p (-33,33%)	5,08M
PRDPredator Oil & Gas Holdings Plc	3,80p (-24,00%)	20,49M
BKSBeeks Financial Cloud Group Plc	195,00p (-23,23%)	2,3M
PHEPowerhouse Energy Group Plc	0,50p (-21,38%)	72,48M
PREMPremier African Minerals Limited	0,01165p (-1,27%)	690,13M
ORCPOracle Power Plc	0,017p (17,24%)	507,12M
CPAICapai Plc	0,1525p (12,96%)	403,35M
UKOGUk Oil & Gas Plc	0,0115p (4,55%)	359,97M
TRPTower Resources Plc	0,0215p (2,38%)	329,04M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Novartis Ag (0K9E)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Novartis Ag

0K9E Dernières nouvelles

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

0K9E - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Novartis Ag (0K9E) Cours

Novartis Ag (0K9E)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Novartis Ag

0K9E Dernières nouvelles

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

0K9E - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités